IBIO as of Nov 2 · 11:12 ET
IBIONasdaqPharmaceutical Preparations

iBio, Inc. · Brief

Next report

9 days

Nov 11 · after closeest.Q1 FY27

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q4 FY26—▼−2.86%—
quarterimplied−5%0+5%realized×
Q4 FY26—▼−2.86%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2 of 3

17disclosed supplier and customer ties in SEC filingsSEC filings
52managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear1

14managers whose positions together make up most of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IBIO report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.